Open AccessAdjuvant radiation provides survival benefit for resected pancreatic adenocarcinomas of the tail
Author(s) -
William Jin,
Sarah E. Hoffe,
Ravi Shridhar,
T. Ström,
Puja Venkat,
Gregory M. Springett,
Pamela Hodul,
José M. Pimiento,
Kenneth Meredith,
Mokenge P. Malafa,
Jessica M. Frakes
Publication year - 2018
Publication title -
journal of gastrointestinal oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.084
H-Index - 39
eISSN - 2219-679X
pISSN - 2078-6891
DOI - 10.21037/jgo.2018.02.02
Subject(s) - medicine , pancreatic cancer , hazard ratio , adjuvant , adenocarcinoma , proportional hazards model , univariate analysis , gastroenterology , confidence interval , adjuvant therapy , radiation therapy , oncology , survival analysis , surgery , multivariate analysis , cancer
The appropriate adjuvant treatment for resected pancreatic cancer remains a controversy. We sought to determine the effect of adjuvant treatment on overall survival (OS) in patients with pancreatic tail adenocarcinoma.